203 related articles for article (PubMed ID: 30291488)
1. Association between clusterin concentration and dementia: a systematic review and meta-analysis.
Yang C; Wang H; Li C; Niu H; Luo S; Guo X
Metab Brain Dis; 2019 Feb; 34(1):129-140. PubMed ID: 30291488
[TBL] [Abstract][Full Text] [Related]
2. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
[TBL] [Abstract][Full Text] [Related]
3. Assessment of CSF Aβ42 as an aid to discriminating Alzheimer's disease from other dementias and mild cognitive impairment: a meta-analysis of 50 studies.
Tang W; Huang Q; Wang Y; Wang ZY; Yao YY
J Neurol Sci; 2014 Oct; 345(1-2):26-36. PubMed ID: 25086857
[TBL] [Abstract][Full Text] [Related]
4. Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.
Tang W; Huang Q; Yao YY; Wang Y; Wu YL; Wang ZY
J Neural Transm (Vienna); 2014 Dec; 121(12):1541-53. PubMed ID: 24817210
[TBL] [Abstract][Full Text] [Related]
5. Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence.
Li X; Wang X; Guo L; Wu K; Wang L; Rao L; Liu X; Kang C; Jiang B; Li Q; Li H; He F; Lu C
Ageing Res Rev; 2023 Aug; 89():101984. PubMed ID: 37330019
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
7. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis.
Khan AA; Quinn TJ; Hewitt J; Fan Y; Dawson J
Age (Dordr); 2016 Feb; 38(1):16. PubMed ID: 26820749
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia.
Amini N; Ibn Hach M; Lapauw L; Dupont J; Vercauteren L; Verschueren S; Tournoy J; Gielen E
J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38715252
[TBL] [Abstract][Full Text] [Related]
10. Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.
Mullan GM; McEneny J; Fuchs M; McMaster C; Todd S; McGuinness B; Henry M; Passmore AP; Young IS; Johnston JA
Curr Alzheimer Res; 2013 Nov; 10(9):973-8. PubMed ID: 24117116
[TBL] [Abstract][Full Text] [Related]
11. Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer's disease.
Quinlan P; Horvath A; Wallin A; Svensson J
Psychoneuroendocrinology; 2019 Jan; 99():112-119. PubMed ID: 30223192
[TBL] [Abstract][Full Text] [Related]
12. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly.
Slot RER; Kester MI; Van Harten AC; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; van der Flier WM; Veerhuis R
Neurobiol Aging; 2019 Jul; 79():101-109. PubMed ID: 31029938
[TBL] [Abstract][Full Text] [Related]
13. Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Tan L; Wang HF; Tan MS; Tan CC; Zhu XC; Miao D; Yu WJ; Jiang T; Tan L; Yu JT;
Sci Rep; 2016 May; 6():26027. PubMed ID: 27229352
[TBL] [Abstract][Full Text] [Related]
14. Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients.
Cai R; Han J; Sun J; Huang R; Tian S; Shen Y; Dong X; Xia W; Wang S
Front Aging Neurosci; 2016; 8():179. PubMed ID: 27516739
[TBL] [Abstract][Full Text] [Related]
15. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
16. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
Zhao Y; Xin Y; Meng S; He Z; Hu W
Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
[TBL] [Abstract][Full Text] [Related]
18. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
[TBL] [Abstract][Full Text] [Related]
20. Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis.
Shi X; Xie B; Xing Y; Tang Y
Curr Alzheimer Res; 2019; 16(11):1018-1027. PubMed ID: 31647395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
